Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data
PaperCitations, authors & open-access status
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 71 citations, 2021 year and gold oa status.
71
Citations
2021
Year
gold
OA Status